Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment

Ana C Garrido-Castro1,2, Nancy U Lin1,2, Kornelia Polyak3,2

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Cancer Discovery
|January 26, 2019
PubMed

Insights

Triple-negative breast cancer (TNBC) is difficult to treat. New classification methods using tumor profiling may improve patient risk stratification and guide the development of targeted therapies.

Area of Science:

  • Oncology
  • Genomics
  • Biomarkers

Background:

  • Triple-negative breast cancer (TNBC) presents significant therapeutic challenges due to its aggressive nature and limited targeted treatment options.
  • Current standard of care relies heavily on chemotherapy, with molecularly targeted therapies showing minimal clinical benefit.
  • TNBC is associated with higher relapse rates, increased metastatic potential, and poorer survival outcomes compared to other breast cancer subtypes.

Purpose of the Study:

  • To review recent advancements in classifying triple-negative breast cancer.
  • To explore the integration of comprehensive tumor profiling data with clinical-pathologic features.
  • To highlight the potential for improved risk stratification, treatment guidance, and novel drug target identification in TNBC.

Main Methods:

  • Review of recent scientific literature on TNBC classification and molecular profiling.
  • Analysis of technological advancements in tumor characterization.
  • Integration of cellular composition and molecular features with clinical-pathologic data.

Main Results:

  • Comprehensive tumor profiling offers new avenues for classifying TNBC.
  • Integration of detailed tumor data with clinical information can enhance patient risk stratification.
  • Emerging data suggests potential for identifying new therapeutic targets and improving treatment strategies.

Conclusions:

  • Advanced tumor characterization is crucial for understanding and treating TNBC.
  • Biomarker identification remains a critical unmet need for guiding TNBC treatment decisions.
  • Understanding resistance mechanisms is key to developing effective novel therapies and improving patient survival.

Related Concept Videos

Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Classification of Elements and Compounds02:54

Classification of Elements and Compounds

Pure substances consist of only one type of matter. A pure substance can be an element or a compound. An element consists of only one type of atom, while a compound consists of two or more types of atoms held together by a chemical bond. Elements are classified as atomic or molecular based on the nature of their basic units.
Compounds are pure substances composed of two or more elements in fixed, definite proportions. Compounds are classified as ionic or molecular (covalent) based on the bonds...
73.1K
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Positive, Negative, and Zero Work00:58

Positive, Negative, and Zero Work

Work is done on an object when energy is transferred to the object. In other words, work is done when a force acts on a body that undergoes a displacement from one position to another. By definition, the work done by a force is the integral of the force with respect to the displacement along its path. Forces can vary as a function of position, and displacements can occur along various paths between two points. The magnitude of a force multiplied by the cosine of the angle that the force makes...
22.1K